title: Misoprostol used alone for the termination of early pregnancy. A review of the evidence.
abstract: Increased access to medical methods of abortion could significantly reduce maternal mortality, especially in developing countries. In light of the political and commercial difficulties in distributing the abortifacient mifepristone, the widely studied mifepristone-misoprostol regimen may not be sufficiently available in the near future. Thus, researchers have begun to look for alternative regimens, including regimens using misoprostol alone. This article reviews the current available evidence on the potential of a misoprostol-alone regimen for medical abortion. Although the data are varied and difficult to compare, recent studies indicate that a misoprostol-alone regimen could be safe and effective as a method of medical abortion. Misoprostol is widely marketed around the world for its other indications and is inexpensive, stable in tropical climates, easy to transport, and simple to administer. A misoprostol-alone regimen of medical abortion could thus greatly improve the access to safe medical abortion services by women in developing countries.
authors.affiliation: Population Council, New York, New York 10017, USA. kblanchard@popcouncil.org
authors.forename: K
authors.initials: K
authors.lastname: Blanchard
authors.forename: B
authors.initials: B
authors.lastname: Winikoff
authors.forename: C
authors.initials: C
authors.lastname: Ellertson
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced; D003462:Cuba; D005260:Female; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D012606:Scotland; D014481:United States
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol